Joao Araujo - Ambipar Emergency Chief Officer

AMBI Stock  USD 6.68  0.13  1.91%   

Executive

Joao Araujo is Chief Officer of Ambipar Emergency Response
Age 51
Address Avenida Angélica, nº 2346, São Paulo, SP, Brazil, 01228-200
Phone55 11 3429 5000
Webhttps://ir-response.ambipar.com

Ambipar Emergency Management Efficiency

The company has return on total asset (ROA) of 0.071 % which means that it generated a profit of $0.071 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1122 %, meaning that it created $0.1122 on every $100 dollars invested by stockholders. Ambipar Emergency's management efficiency ratios could be used to measure how well Ambipar Emergency manages its routine affairs as well as how well it operates its assets and liabilities. The Ambipar Emergency's current Return On Tangible Assets is estimated to increase to -0.02. The current Return On Capital Employed is estimated to decrease to 0.1. As of now, Ambipar Emergency's Intangible Assets are increasing as compared to previous years. The Ambipar Emergency's current Intangibles To Total Assets is estimated to increase to 0.46, while Total Assets are projected to decrease to under 2.2 B.
Ambipar Emergency Response currently holds 1.93 B in liabilities with Debt to Equity (D/E) ratio of 0.03, which may suggest the company is not taking enough advantage from borrowing. Ambipar Emergency has a current ratio of 3.95, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Ambipar Emergency's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

Frances KlingleAvalon Holdings
77
JD BSFSLanzaTech Global
57
Omar ElSharkawyLanzaTech Global
N/A
Geoffrey TrukenbrodLanzaTech Global
51
Steven StanleyLanzaTech Global
61
Carl WolfLanzaTech Global
38
Nilesh KumarLanzaTech Global
N/A
Kate WalshLanzaTech Global
N/A
Robert ConradoLanzaTech Global
40
Chad ThompsonLanzaTech Global
54
Zara SummersLanzaTech Global
41
Marjorie PattersonAvalon Holdings
N/A
Michael HavaloAvalon Holdings
39
Johann ClereLanzaTech Global
N/A
Freya BurtonLanzaTech Global
43
Johanna HaggstromLanzaTech Global
45
Stefanie VillellaAvalon Holdings
N/A
Ambit Biosciences Corporationration, a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of oncology, autoimmune, and inflammatory diseases in the United States. Ambipar Emergency Response (AMBI) is traded on NYSE MKT Exchange in USA. It is located in Avenida Angélica, nº 2346, São Paulo, SP, Brazil, 01228-200 and employs 7,089 people. Ambipar Emergency is listed under Environmental & Facilities Services category by Fama And French industry classification.

Management Performance

Ambipar Emergency Leadership Team

Elected by the shareholders, the Ambipar Emergency's board of directors comprises two types of representatives: Ambipar Emergency inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ambipar. The board's role is to monitor Ambipar Emergency's management team and ensure that shareholders' interests are well served. Ambipar Emergency's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ambipar Emergency's outside directors are responsible for providing unbiased perspectives on the board's policies.
Shannon Riley, President America
Dennys Maio, President Brazil
Pablo Chateau, President America
Pedro Petersen, Chief Officer
Martin Lehane, President Europe
Rafael Santo, Chief Officer
Joao Araujo, Chief Officer
Simone Hirakuri, Global officer

Ambipar Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ambipar Emergency a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

When determining whether Ambipar Emergency offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ambipar Emergency's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ambipar Emergency Response Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ambipar Emergency Response Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ambipar Emergency Response. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Environmental & Facilities Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ambipar Emergency. If investors know Ambipar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ambipar Emergency listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.422
Earnings Share
0.25
Revenue Per Share
133.296
Quarterly Revenue Growth
0.21
Return On Assets
0.071
The market value of Ambipar Emergency is measured differently than its book value, which is the value of Ambipar that is recorded on the company's balance sheet. Investors also form their own opinion of Ambipar Emergency's value that differs from its market value or its book value, called intrinsic value, which is Ambipar Emergency's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ambipar Emergency's market value can be influenced by many factors that don't directly affect Ambipar Emergency's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ambipar Emergency's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ambipar Emergency is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ambipar Emergency's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.